Health Care/Hospital
Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, May 17, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the"Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeuti...
2023-05-17 21:13
2811
Smart Home Healthcare Revenues Grow to US$26.5 Billion in 2023, Driven by the Remote Monitoring Opportunity
NEW YORK, May 17, 2023 /PRNewswire/ -- The smart home healthcare market continues to grow, but the scale of the opportunity remains underpenetrated. Last year, new smart home healthcare shipment and service revenues grew 25% to reachUS$22.9 billion worldwide, but that growth rate will be hard to ...
2023-05-17 20:30
2044
Frost and Sullivan Institute launches Enlightened Growth Leadership Awards, 2023 for Emerging Companies Dedicated to 'Innovating to Zero'.
SANTA CLARA, Calif., May 17, 2023 /PRNewswire/ -- The Enlightened Growth Leadership Best Practices Recognition, 2023 for Emerging Companies* honors startup companies that are focused on developing innovative products and services that address global challenges while creating a positive impact on ...
2023-05-17 20:16
1949
United Imaging Unveils a Full Portfolio of Products at CMEF 2023, Highlighting Its AI Capabilities across Modalities
SHANGHAI, May 17, 2023 /PRNewswire/ -- United Imaging unveiled its full range
of products, including PET/CT, PET/MR, MR, CT, DR, RT, and digital solutions,
at the China International Medical Equipment Fair (CMEF) recently, highlighting
the products' AI capacity across modalities.
2023-05-17 20:00
2933
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023
SHANGHAI, May 17, 2023 /PRNewswire/ -- Skyline Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, is showcasing multiple data presentations at the American Society of Gene and Cell Therapy ...
2023-05-17 18:00
1858
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
NEW YORK, May 17, 2023 /PRNewswire/ -- Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it groundbreakingly combines two rapidly developing technologies, quantum computing and generative AI to explore the lead candidat...
2023-05-17 18:00
2859
Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases
Uniting to Combat Neglected Tropical Diseases (unitingtocombatntds.org) releases letter signed by 36 Parliamentarians from 23 countries calling on G7 Leaders to invest in NTDs. LONDON, May 17, 2023 /PRNewswire/ -- To: Fumio Kishida, Prime Minister, Japan (Host) Joe Biden, President, United Stat...
2023-05-17 17:40
2574
Inclusion of Recbio In the MSCI China Small Cap Index
TAIZHOU, China, May 17, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, MSCI announced the results of the semi-annual review of the MSCI Global Small Cap Indexes onMay 12, 2023, and the Company has ...
2023-05-17 14:01
5494
Antengene Announces NDA Submission for XPOVIO® in Indonesia
SHANGHAI and HONG KONG, May 17, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hema...
2023-05-17 08:30
2621
Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density
SUZHOU, China, May 17, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces encouraging phase I cl...
2023-05-17 08:17
2168
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings
ROCKVILLE, Md. and SUZHOU, China, May 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-05-17 08:00
4123
Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia
SHANGHAI, May 17, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment in a multi-...
2023-05-17 07:48
3647
DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
* Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. * Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA dama...
2023-05-17 07:00
2055
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022
NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...
2023-05-17 05:00
3027
Fresh2 Reports Fiscal Year 2022 Annual Financial Results
NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd. ,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...
2023-05-17 04:15
2420
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results
NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and entering into the operation of a ...
2023-05-17 04:15
2396
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
MILFORD, Mass., May 17, 2023 /PRNewswire/ -- Waters™ Corporation (NYSE: WAT) today announced it has completed its acquisition of Wyatt Technology, a pioneer and well-recognized leader in innovative light scattering and field-flow fractionation instruments, software, accessories, and services. Wi...
2023-05-17 04:15
5720
Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB-301) Program to Treat Corneal Blindness
Awarded Honors at the American Society of Cataract and Refractive Surgery (ASCRS) andthe Association for Research in Vision and Ophthalmology (ARVO) SUZHOU, China and SAN FRANCISCO, May 16, 2023 /PRNewswire/ -- Eluminex Biosciences (Eluminex) announced that its clinical pivotal study (CLARITY) e...
2023-05-16 23:00
1744
Boan Biotech's BA1202 Approved for Clinical Trial
-The First Novel CEA/CD3 Bispecific Antibody in China- YANTAI, China, May 16, 2023 /PRNewswire/ -- Boan Biotech announced today that its BA1202, a CEACAM5 (CEA)/CD3 bispecific antibody, has been approved for a clinical trial by the Center for Drug Evaluation ofChina's National Medical Products A...
2023-05-16 22:02
5283
The first spring CMEF exhibition after the COVID-19 pandemic in the Chinese mainland: A brief discussion on the rise and challenges of China's domestic medical apparatus from Diagens Biotechnology
SHANGHAI, May 16, 2023 /PRNewswire/ -- From May 14th to 17th, 2023, a global medical technology event kicked off inChina. The 87th China International Medical Equipment (Spring)Fair (CMEF) attracted industry elites from more than 20 countries and regions around the world under the theme of "Innov...
2023-05-16 21:39
1919
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 310 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 282 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
7371
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
6145
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
5052
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
4707
